Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.
Umar MehrajHina QayoomManzoor Ahmad MirPublished in: Breast cancer (Tokyo, Japan) (2021)
Macrophages are phagocytic sentinel cells of the immune system that are central to both innate and adaptive immune responses and serve as the first line of defense against pathogenic insults to tissues. In the tumor microenvironment, tumor-derived factors induce monocyte polarization towards a pro-tumor phenotype. The pro-tumor macrophages regulate key steps in tumorigenicity including tumor growth, angiogenesis, immune suppression, and metastasis. Macrophage infiltration in solid tumors correlates with poor prognosis and resistance to chemotherapy in most cancers. Here in this review, we will shed light on tumor-associated macrophages (TAMs) in regulating tumorigenicity and TAMs as a prognostic biomarker. Also, we will review the recent advances in targeting TAMs to increase the prognosis of cancer patients.
Keyphrases
- poor prognosis
- immune response
- endothelial cells
- induced apoptosis
- dendritic cells
- gene expression
- cancer therapy
- adipose tissue
- papillary thyroid
- cell cycle arrest
- anti inflammatory
- cell proliferation
- vascular endothelial growth factor
- toll like receptor
- squamous cell
- endoplasmic reticulum stress
- young adults
- peripheral blood
- radiation therapy